HNCTX | RERGX | HNCTX / RERGX | |
Total Expense Ratio | 1.00 | 0.47 | 213% |
Annual Report Gross Expense Ratio | 1.01 | 0.47 | 215% |
Fund Existence | 19 years | 16 years | - |
Gain YTD | 20.620 | 14.706 | 140% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 341M | 135B | 0% |
Annual Yield % from dividends | 0.29 | 0.95 | 30% |
Returns for 1 year | 24.18 | 10.20 | 237% |
Returns for 3 years | 59.43 | 31.12 | 191% |
Returns for 5 years | 33.65 | 16.38 | 205% |
Returns for 10 years | 69.18 | 30.59 | 226% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SYNB | 29.78 | 0.19 | +0.66% |
Putnam BioRevolution ETF | |||
LQTI | 20.14 | 0.04 | +0.22% |
FT Vest Investment Grade & Target Income ETF | |||
AVIG | 41.37 | 0.09 | +0.21% |
Avantis Core Fixed Income ETF | |||
GNOV | 37.05 | 0.06 | +0.16% |
FT Vest U.S. Eq Mod Buffr ETF - Nov | |||
IBHJ | 26.55 | 0.03 | +0.13% |
iShares iBonds 2030 Term Hi Yld & IncETF |